N-methyl-N-(1-(2-((1-methyl-1H-pyrazol-5-yl)amino)benzoyl)piperidin-4-yl)-4-acetyl-benzamide

ID: ALA4646599

PubChem CID: 156019808

Max Phase: Preclinical

Molecular Formula: C26H29N5O3

Molecular Weight: 459.55

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CC(=O)c1ccc(C(=O)N(C)C2CCN(C(=O)c3ccccc3Nc3ccnn3C)CC2)cc1

Standard InChI:  InChI=1S/C26H29N5O3/c1-18(32)19-8-10-20(11-9-19)25(33)29(2)21-13-16-31(17-14-21)26(34)22-6-4-5-7-23(22)28-24-12-15-27-30(24)3/h4-12,15,21,28H,13-14,16-17H2,1-3H3

Standard InChI Key:  ZURYVCJOLFOBMS-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 34 37  0  0  0  0  0  0  0  0999 V2000
   17.5819  -11.2316    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.3974  -11.2328    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.8043  -10.5283    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.3969   -9.8222    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.5784   -9.8250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.1751  -10.5301    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.1735  -11.9394    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   16.3563  -11.9396    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.8054  -11.9408    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.3962  -12.6482    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   19.6226  -11.9414    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   20.0270  -12.6509    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.8406  -12.6535    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.2536  -11.9480    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.8468  -11.2381    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.0270  -11.2338    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.8727  -11.2811    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.0955  -11.5338    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.0957  -12.3511    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   15.8730  -12.6033    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   16.1252  -13.3806    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.0708  -11.9517    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   22.4761  -12.6613    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.4826  -11.2459    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.0643  -13.3671    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.2933  -12.6650    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   21.2492  -13.3605    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.8374  -14.0655    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.2428  -14.7760    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.0643  -14.7771    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.4723  -14.0715    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.8320  -15.4824    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.0148  -15.4797    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   21.2383  -16.1914    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  1  1  0
  1  7  1  0
  7  8  1  0
  2  9  1  0
  9 10  2  0
  9 11  1  0
 11 12  1  0
 11 16  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
  8 17  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20  8  1  0
 20 21  1  0
 14 22  1  0
 22 23  1  0
 22 24  1  0
 23 25  1  0
 23 26  2  0
 25 27  2  0
 27 28  1  0
 28 29  2  0
 29 30  1  0
 30 31  2  0
 31 25  1  0
 29 32  1  0
 32 33  2  0
 32 34  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4646599

    ---

Associated Targets(Human)

SMO Tclin Smoothened homolog (1371 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 459.55Molecular Weight (Monoisotopic): 459.2270AlogP: 3.74#Rotatable Bonds: 6
Polar Surface Area: 87.54Molecular Species: NEUTRALHBA: 6HBD: 1
#RO5 Violations: HBA (Lipinski): 8HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 3.26CX LogP: 3.19CX LogD: 3.19
Aromatic Rings: 3Heavy Atoms: 34QED Weighted: 0.57Np Likeness Score: -1.69

References

1. Ji D, Zhang W, Xu Y, Zhang JJ..  (2020)  Design, synthesis and biological evaluation of anthranilamide derivatives as potent SMO inhibitors.,  28  (6): [PMID:32063403] [10.1016/j.bmc.2020.115354]

Source